Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Frazier Life Sciences Viii, L.p.


  • Large Shareholder at Alpine Immune Sciences Inc. (ALPN), 2019-01-22
  • Large Shareholder at Entasis Therapeutics Holdings Inc. (ETTX), 2018-10-03
  • Large Shareholder at Aptinyx Inc. (APTX), 2018-06-26
  • Large Shareholder at Sierra Oncology Inc. (SRRA), 2017-02-24
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALPN $5.37 372,439 Large Shareholder 2,571,450 2019-01-18 Filing
ETTX $15.00 375,887 Large Shareholder 1,349,953 2018-09-28 Filing
APTX $16.00 150,000 Large Shareholder 3,190,079 2018-06-25 Filing